Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Nanomedicine. 2019 Nov 26;24:102127. doi: 10.1016/j.nano.2019.102127

Table 3.

Characterization of MCD3 ASO-SHA NP nanocomplexes

size and zeta potential Size [nm] (average ± SD) Zeta potential [mV] (average ± SD)
SHA NP 28.2±1.9 −9.6 ± 0.2
SHA NP (+azide) 30.8 ± 1.7 −6.4 ± 0.7
MXD3 ASO-SHA NP nanocomplexes 38.9 + 1.3 14.8 ±0.4
ASO loading MXD3 ASO[μg] [%] of total Bound ASO molecules per nanoparticle
MXD3 ASO-SHA NP nanocomplex pellet (bound MXD3 ASO) 3.0 10.1 60.6
Supernatant (unbound MXD3 ASO) 26.0 88.9

SD: standard deviation